CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase I/II Study of Concurrent Cetuximab and Nivolumab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03370276
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:04.308752+00:00
- Published At
- 2022-12-20T00:00:00+00:00
- Record Updated At
- 2026-04-02
- Results Posted At
- 2022-12-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Squamous Cell Carcinoma of the Oropharynx", "Squamous Cell Carcinoma of the Larynx", "Squamous Cell Carcinoma of the Oral Cavity", "Squamous Cell Carcinoma of the Hypopharynx", "Squamous Cell Carcinoma of the Paranasal Sinus", "Head and Neck Squamous Cell Carcinoma", "Squamous Cell Cancer", "Head and Neck Carcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-02"- protocolSection.identificationModule.nctId
"NCT03370276"- protocolSection.identificationModule.officialTitle
"A Phase I/II Study of Concurrent Cetuximab and Nivolumab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-12-20"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.